Recent events
Recent events tied to this brand in public sources.
Back to profile8 entries
2026
Pennsylvania sues insulin makers and PBMs over alleged insulin price collusion
Pennsylvania sued Eli Lilly and Co., Novo Nordisk Inc., Sanofi-Aventis US LLC, and several PBMs, alleging that they colluded to raise insulin prices. The lawsuit seeks structural changes, restitution, and financial penalties.
2026
UnitedHealth Group posts Q3 2026 earnings above estimates
On Oct 13, 2026, UnitedHealth Group reported third-quarter adjusted earnings per share of $4.69 versus $4.14 expected and revenue of $112.69 billion versus $111.40 billion expected, with third-quarter net income of $4.11 billion; its UnitedHealthcare and Optum units both topped analysts' operating earnings estimates for the quarter.
2026
Maryland AG sues UnitedHealth Group and Optum over Medicaid system
Maryland Attorney General Anthony Brown sued UnitedHealth Group and Optum, Inc., alleging they defrauded the state Medicaid Program by supplying a defective computer system.
2022
US Justice Department sues to block UnitedHealth–Change Healthcare acquisition
The Department of Justice filed a lawsuit against UnitedHealth Group to block its planned acquisition of Change Healthcare, alleging that the merger would harm competition in commercial health markets and healthcare technology markets.
2021
CBIZ acquires Optumas
CBIZ acquired Schramm Health Partners, LLC, doing business as Optumas, effective June 1, 2021.
2020
Lackie Drug Store sues pharmacy benefit managers over alleged anticompetitive practices
Lackie Drug Store Inc. filed a case in Lonoke County Circuit Court alleging that pharmacy benefit managers, including CVS Health Corporation and Caremark entities, used reimbursement methodologies and practices that were anticompetitive. The allegations include withholding Maximum Allowable Cost information and conspiracy regarding pricing rates; the source reports allegations, not a determination.
2019
Harris County files insulin price-fixing lawsuit
Harris County sued insulin manufacturers Eli Lilly, Novo Nordisk and Sanofi, along with pharmaceutical benefit managers Aetna Rx, CVS Caremark, Express Scripts and OptumRx, alleging they colluded to drive up insulin prices. The county seeks to recover more than $27 million it says it has paid to the companies.
2019
Optum acquires Vivify Health
Optum, a division of UnitedHealth, acquired patient-monitoring start-up Vivify Health; the deal terms were not disclosed.